Skip to content

To compare between the effect of shuddhabala taila nasya and karpasasthyadi taila nasya in the management of ardita

A randomized controled clinical study to evaluate the efficacy of shuddhabala taila nasya and karpasasthyadi taila nasya in the management of ardita - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082859
Enrollment
40
Registered
2025-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G510- Bells palsy

Interventions

None listed

Sponsors

Dr D Devi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient presenting with classical signs and symptoms of Ardita Patients from either sex were selected in the age group of 14-60 years. Patients fit for Nasya Karma

Exclusion criteria

Exclusion criteria: More than 3 years of history. Ardita associated with Pakshagata, Bilateral facial nerve paralysis, intracranial hemorrhage, neoplasm, Multiple sclerosis. Patient with other systemic disorders which interfere with course of treatment, and auto immune disorders. Un-controlled diabetic mellitus. Pregnant women.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Shuddhabala taila nasya in the management of arditaTimepoint: 6 months

Secondary

MeasureTime frame
To compare the efficacy of karpasasthyadi taila nasya & shuddhabala taila nasya in the management of arditaTimepoint: 6 months

Countries

India

Contacts

Public ContactDr Suresh N Hakkandi

Shree Jagadguru Gavisiddheshwara Ayurvedic Medical College and Hospital

sureshhakkandi@gmail.com9448609362

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026